Psilocybin, GLP-1s, marijuana policy and more BH updates

April 23, 2026

1. What is psilocybin? Inside Trump's push for psychedelic treatments Full story

2. 'It buys patients time': GLP-1s show early promise in addiction treatment Full story

3. Data isn't the problem — action is. How 3 systems embed AI into care workflows here.

 

4. Care New England rolls out Butler Behavioral Health brand Full story

5. Justice Department reclassifies marijuana products: What it means for healthcare Full story

6. Outpatient pressures are pushing leaders to rethink AI in the EHR — see how here.

 

7. AMA urges federal oversight of mental health chatbots Full story

8. Clinicians produce higher-quality notes than AI scribes: Study Full story

9. Missouri hospital files for bankruptcy, pursues sale Full story

10. 121 best healthcare employers for culture: Forbes Full story

 

Becker's Learning Opportunities

11. Virtual behavioral health carries real risk — 20 criteria hospital leaders should evaluate now, here.

12. Workforce instability isn't going away. Learn how to lead through it here.

13. Can IT and care management improve together? This case study says yes. See it here.

14. Becker's resources don't stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication